Testing effectiveness (Phase 2)Study completedNCT00029107
What this trial is testing
Rituximab to Treat Hepatitis C-Associated Cryoglobulinemic Vasculitis
Who this might be right for
Hepatitis CVasculitis
National Institute of Allergy and Infectious Diseases (NIAID) 47